{"database": "lobbying", "table": "lobbying_activities", "rows": [[2188377, "ca822f23-328e-4672-b33e-1bb4616eb35e", "Q3", "FTI GOVERNMENT AFFAIRS", 401054971, "PROFESSIONAL COMPOUNDING CENTERS OF AMERICA", 2018, "third_quarter", "PHA", "Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 \"Preserving Patient Access to Compounded Medication Act of 2017. \"", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2018-10-17T15:01:58.130000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2188377"], "units": {}, "query_ms": 10.06584893912077, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}